How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from Gatorade, Marriott, Alo Yoga, Campbell's, Uncommon James and more. Book now.
NEW YORK Publicis Groupe’s Saatchi & Saatchi has landed Novartis’ Excedrin account without a review, sources said.
The client spent $25 million in measured media on the brand from January through May 2005, per Nielsen Monitor-Plus.
A representative for the New York agency referred calls to client officials, who did immediately respond.
Independent
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in